These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10392439)

  • 1. [Characteristics of reactogenic and immunogenic properties of the children's variant of the domestic vaccine, "Gep-A-in-Vak", against hepatitis A].
    Ikoev VN; Gorbunov MA; Maĭdaniuk AG; Karpovich LG; Kalashnikova TV; Bektimirov TA; Karpova EV; Nemtsov IuV; Muntlieva MA; Kriuk NI
    Vopr Virusol; 1999; 44(3):133-6. PubMed ID: 10392439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the immunogenicity of the inactivated hepatitis A vaccine Hep-A-in-vac from experimental and clinical data].
    Karpovich LG; Kalashnikova TV; Gorbunov MA; Pavlova LI; Bektimirov TA; Maĭdaniuk AG; Sandakhchiev LS; Levina VD; Ermolaeva TN; Rodomazova TA
    Vopr Virusol; 1995; 40(6):268-70. PubMed ID: 8686264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 4. The success of hepatitis A vaccine.
    Sjogren MH
    Gastroenterology; 1993 Apr; 104(4):1214-6. PubMed ID: 8385043
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of inactivated hepatitis A vaccine in children.
    Lee SD; Lo KJ; Chan CY; Yu MY; Wang YJ; Safary A
    Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections.
    Can Commun Dis Rep; 1994 Aug; 20(16):133-43. PubMed ID: 7951129
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with an inactivated hepatitis A vaccine.
    Clemens R; Safary A; Hepburn A; Roche C; Stanbury WJ; André FE
    J Infect Dis; 1995 Mar; 171 Suppl 1():S44-9. PubMed ID: 7876648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of "Avaxim" hepatitis A vaccine produced by the firm "Pasteur Merrier" (results of field clinical trials)].
    Gorbunov MA; Noskova AV; El'shina GA; Bektimirov TA; Pavlova LI; Aksenov LA; Ivanov AA
    Vopr Virusol; 2000; 45(1):39-42. PubMed ID: 10695044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hep-A-in-Vac, a Russian cultured concentrated inactivated vaccine against hepatitis A].
    Gorbunov MA; Pavlova LI; Rozhkov SD; Kukharev AI; Novikov VIu; Karpovich LG; Kalashnikova TV; Bektimirov TA; Zelenov IA; Levina VD; Belashev BP; Ermolaeva TN; Doroshenko NV; Maĭdaniuk AT
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):50-4. PubMed ID: 9532686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule.
    Westblom TU; Gudipati S; DeRousse C; Midkiff BR; Belshe RB
    J Infect Dis; 1994 May; 169(5):996-1001. PubMed ID: 8169430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the reactivity, safety and immunogenicity of "Havrix" inactivated hepatitis A vaccine].
    Noskova AV; Gorbunov MA; Pavlova LI; El'shina GA; Sharipova IS; Karpovich LG; Kalashnikova TI; Bektimirov TA; Rikhmer VV; El'nikov VS
    Vopr Virusol; 2000; 45(6):42-4. PubMed ID: 11200647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against hepatitis A by an inactivated vaccine.
    Innis BL; Snitbhan R; Kunasol P; Laorakpongse T; Poopatanakool W; Kozik CA; Suntayakorn S; Suknuntapong T; Safary A; Tang DB
    JAMA; 1994 May; 271(17):1328-34. PubMed ID: 8158817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A and vaccination.
    Teuwen DE
    Arch Inst Pasteur Tunis; 1994; 71(3-4):549-56. PubMed ID: 8801857
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
    Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
    Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers.
    Wagner G; Lavanchy D; Darioli R; Pécoud A; Brulein V; Safary A; Frei PC
    Vaccine; 1993; 11(10):1027-32. PubMed ID: 8212822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.